Literature DB >> 19539222

Lamivudine prophylaxis and hepatitis B vaccination for prevention of hepatitis B virus reverse seroconversion in long-term survivors after allogeneic stem cell transplantation.

Quan Le, Aarthi Shenoy, Eleftheria Koklanaris, Richard Childs, A John Barrett, Bipin N Savani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19539222      PMCID： PMC3759997          DOI： 10.1016/j.bbmt.2009.03.024

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  9 in total

1.  Increased risk of bone loss without fracture risk in long-term survivors after allogeneic stem cell transplantation.

Authors:  Bipin N Savani; Theresa Donohue; Eleftheria Kozanas; Aarthi Shenoy; Anurag K Singh; Richard W Childs; A John Barrett
Journal:  Biol Blood Marrow Transplant       Date:  2007-05       Impact factor: 5.742

2.  Lamivudine prophylaxis and treatment of hepatitis B Virus-exposed recipients receiving reduced intensity conditioning hematopoietic stem cell transplants with alemtuzumab.

Authors:  S E Moses; Z Y Lim; M Sudhanva; S Devereux; A Y L Ho; A Pagliuca; M Zuckerman; G J Mufti
Journal:  J Med Virol       Date:  2006-12       Impact factor: 2.327

3.  Hepatitis B virus reactivation in a patient with chronic GVHD after allogeneic peripheral blood stem cell transplantation.

Authors:  H Sakamaki; Y Sato; S I Mori; K Ohashi; S Tanikawa; H Akiyama; T Sasaki; K Hiruma
Journal:  Int J Hematol       Date:  2001-10       Impact factor: 2.490

4.  Adoptive transfer of immunity to hepatitis B virus after T cell-depleted allogeneic bone marrow transplantation.

Authors:  Y Ilan; A Nagler; R Adler; E Naparstek; R Or; S Slavin; C Brautbar; D Shouval
Journal:  Hepatology       Date:  1993-08       Impact factor: 17.425

5.  Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor.

Authors:  A Knöll; S Boehm; J Hahn; E Holler; W Jilg
Journal:  J Viral Hepat       Date:  2007-07       Impact factor: 3.728

6.  Progressive disappearance of anti-hepatitis B surface antigen antibody and reverse seroconversion after allogeneic hematopoietic stem cell transplantation in patients with previous hepatitis B virus infection.

Authors:  Masahiro Onozawa; Satoshi Hashino; Koh Izumiyama; Kaoru Kahata; Makoto Chuma; Akio Mori; Takeshi Kondo; Nobuyasu Toyoshima; Shuichi Ota; Sumiko Kobayashi; Shuhei Hige; Tomomi Toubai; Junji Tanaka; Masahiro Imamura; Masahiro Asaka
Journal:  Transplantation       Date:  2005-03-15       Impact factor: 4.939

7.  Reactivation of resolved hepatitis B virus infection after allogeneic haematopoietic stem cell transplantation.

Authors:  A Knöll; S Boehm; J Hahn; E Holler; W Jilg
Journal:  Bone Marrow Transplant       Date:  2004-05       Impact factor: 5.483

8.  HB vaccination in the prevention of viral reactivation in allogeneic hematopoietic stem cell transplantation recipients with previous HBV infection.

Authors:  Masahiro Onozawa; Satoshi Hashino; Stephanie Darmanin; Kohei Okada; Rena Morita; Mutsumi Takahata; Akio Shigematsu; Kaoru Kahata; Takeshi Kondo; Junji Tanaka; Masahiro Imamura; Masahiro Asaka
Journal:  Biol Blood Marrow Transplant       Date:  2008-11       Impact factor: 5.742

9.  Reactivation of hepatitis B virus in two chronic GVHD patients after transplant.

Authors:  P M Chen; S Fan; J H Liu; T J Chiou; S R Hsieh; R S Liu; C H Tzeng
Journal:  Int J Hematol       Date:  1993-10       Impact factor: 2.490
  9 in total
  2 in total

1.  Favorable outcomes in patients surviving 5 or more years after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.

Authors:  Robert Quan Le; Margaret Bevans; Bipin N Savani; Sandra A Mitchell; Kate Stringaris; Eleftheria Koklanaris; A John Barrett
Journal:  Biol Blood Marrow Transplant       Date:  2010-03-17       Impact factor: 5.742

Review 2.  HBV Reactivation in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Narrative Review.

Authors:  Giuseppe Gentile; Guido Antonelli
Journal:  Viruses       Date:  2019-11-10       Impact factor: 5.048
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.